- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03523260
Comparison of High-Flow Hemodialysis Catheters Placed From the Left Internal Jugular Vein(R12-022)
May 6, 2021 updated by: Husameddin M El Khudari, University of Alabama at Birmingham
High-Flow Hemodialysis Catheters Placed Through the Left Internal Jugular Approach (R12-022)
The patient population for this study is individuals requiring high-flow polyurethane tunneled dialysis catheters (TDC) for hemodialysis access.
The primary objective of this study is to compare outcomes of participants who undergo left internal jugular placement of a split-tip versus a step-tip versus symmetric tip catheter.
This study will review and compare the complication rate and function of the three catheter designs.
Study Overview
Status
Withdrawn
Intervention / Treatment
Detailed Description
The patient population for this study is individuals requiring high-flow polyurethane tunneled dialysis catheters (TDC) for hemodialysis access.
The primary objective of this study is to compare outcomes of participants who undergo left internal jugular placement of a split-tip versus a step-tip versus symmetric tip catheter.
Participants will be randomized to receive a split-tip, step-tip or symmetric tip catheter in a 1:1:1 ratio.
All participants will be followed per their referring physician's standard of care.
Information regarding any patient complications will be obtained from Dr. Allon's dialysis patient database (Vascular Access in Hemodialysis Patients, IRB # X980813005).
This study will review and compare the complication rate and function of the three catheter designs.
There are no studies to our knowledge that compared catheter designs placed specifically via the left internal jugular vein.
The investigators hypothesize that because the left internal jugular vein is anatomically more complex than the right one, tunneled dialysis catheters with split-tip design may perform sub-optimally, compared to step-tip and symmetric tip designs, when placed via the left internal jugular vein.
If this hypothesis is true, the results of the study may influence future clinical practice and reduce the rates of replacement of catheters placed through the left internal jugular vein, resulting in better patient care and significant cost-savings.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35249
- University of Akabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Willing and able to provide a written informed consent
- 19 years or older
- Hemodialysis patient needing high-flow polyurethane tunneled dialysis catheter placement via the left internal jugular vein.
- Patent left internal jugular vein.
- Able to read and understand English.
Exclusion Criteria:
- Previous enrollment in this trial
- Patients unable or unwilling to provide informed consent
- Prisoners or incarcerated individuals
- Women who are pregnant
- Patients in whom the left internal jugular vein is occluded or catheter placement is otherwise contraindicated
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Tunneled dialysis Split-tip catheter
High-flow tunneled Split-tip catheter for hemodialysis will be inserted by standard interventional technique
|
Placement of high-flow tunneled catheter for hemodialysis
|
Active Comparator: Tunneled dialysis Step-tip catheter
High-flow tunneled Step-tip catheter for hemodialysis will be inserted by standard interventional technique
|
Placement of high-flow tunneled catheter for hemodialysis
|
Active Comparator: Tunneled dialysis Symmetric tip catheter
High-flow tunneled Symmetric tip catheter for hemodialysis will be inserted by standard interventional technique
|
Placement of high-flow tunneled catheter for hemodialysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complication rate
Time Frame: 1 month
|
1 month complication rate of left internal jugular vein dialysis catheters
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Catheter dysfunction
Time Frame: 1 months
|
1 month complication rate of left internal jugular vein dialysis catheters
|
1 months
|
Catheter dysfunction
Time Frame: 3 months
|
3 months complication rate of left internal jugular vein dialysis catheters
|
3 months
|
Catheter dysfunction
Time Frame: 6 months
|
6 months complication rate of left internal jugular vein dialysis catheters
|
6 months
|
Complication rate
Time Frame: 3 months
|
3 months complication rate of left internal jugular vein dialysis catheters
|
3 months
|
Complication rate
Time Frame: 6 months
|
6 months complication rate of left internal jugular vein dialysis catheters
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 27, 2013
Primary Completion (Actual)
January 22, 2020
Study Completion (Actual)
January 22, 2020
Study Registration Dates
First Submitted
February 7, 2018
First Submitted That Met QC Criteria
May 1, 2018
First Posted (Actual)
May 14, 2018
Study Record Updates
Last Update Posted (Actual)
May 10, 2021
Last Update Submitted That Met QC Criteria
May 6, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-130430002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Renal Disease on Dialysis (Diagnosis)
-
Indigo TherapeuticsBioFortisUnknownEnd Stage Renal Disease on Dialysis (Diagnosis)France
-
University Health Network, TorontoNot yet recruitingEnd Stage Renal Disease on Dialysis (Diagnosis)Canada
-
Peripal AGUniversity Hospital Birmingham NHS Foundation Trust; Swiss Federal Institute...CompletedRenal Failure | Peritoneal Dialysis | Renal Replacement Therapy | End Stage Renal Failure on Dialysis | End Stage Renal Disease on DialysisUnited Kingdom
-
Queen's University, BelfastCompletedFeasibility Study | End Stage Renal Disease on Dialysis (Diagnosis)United Kingdom
-
Satellite HealthcareCompletedEnd Stage Renal Disease on Dialysis | Home DialysisUnited States
-
Sun Yat-sen UniversityRecruiting
-
Nanyang Technological UniversityNational Kidney Foundation, SingaporeRecruitingEnd Stage Renal Disease | End Stage Kidney Disease | End Stage Renal Failure on Dialysis | End Stage Renal Disease on DialysisSingapore
-
Outset MedicalCompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on DialysisUnited States
-
Centre Hospitalier Universitaire de BesanconRecruitingPeritoneal Dialysis | End Stage Renal Disease on DialysisFrance
-
Kaohsiung Medical University Chung-Ho Memorial...National Sun Yat-sen UniversityRecruiting
Clinical Trials on Tunneled dialysis catheter placement.
-
Brigham and Women's HospitalUnknown
-
University of California, Los AngelesWithdrawnCongestive Heart Failure | Shortness of Breath | Pleural Effusions, ChronicUnited States
-
Shanghai Changzheng HospitalFirst Affiliated Hospital of Zhejiang University; The First Affiliated Hospital... and other collaboratorsUnknownEnd Stage Renal DiseaseChina
-
Medical University of ViennaUnknownEnd Stage Renal Disease | Catheter Infection | Shunt MalfunctionAustria
-
AZ Sint-Jan AVCompletedCatheter Related Bloodstream Infection | Chronic Hemodialysis | Mechanical Catheter DysfunctionBelgium
-
University of California, Los AngelesAngiodynamics, Inc.TerminatedChronic Kidney DiseaseUnited States
-
Chinese University of Hong KongCompletedRenal Failure | End-stage Renal DiseaseHong Kong
-
Tanta UniversityCompletedDialysis Catheter; MalpositionEgypt
-
Washington University School of MedicineCompleted
-
University of MichiganWithdrawnVascular Access ComplicationUnited States